Asthma, FEF25-75, and Hospitalizations in Children

Elizabeth R Gibb1, Shannon M Thyne2, Daniel N Kaplan1

  • 1Division of Pulmonary Medicine, Department of Pediatrics, Benioff Children's Hospital, University of California, San Francisco, California.

Insights

Reduced forced expiratory flow between 25%-75% (FEF25-75) in children with asthma may predict hospitalizations, even with normal forced expiratory volume in 1 second (FEV1). This finding suggests FEF25-75 is crucial for assessing pediatric asthma control.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Pediatrics

Background:

  • Asthma is a prevalent chronic respiratory condition in children, contributing to significant morbidity.
  • Current asthma management guidelines emphasize monitoring forced expiratory volume in 1 second (FEV1).
  • However, a normal FEV1 in children does not always correlate with well-controlled asthma symptoms or severity.

Purpose of the Study:

  • To investigate the association between reduced forced expiratory flow between 25%-75% of vital capacity (FEF25-75) and asthma-related hospitalizations in children.
  • To determine if FEF25-75 is a valuable indicator of asthma severity and control, particularly in children with a normal FEV1.

Main Methods:

  • Retrospective review of pulmonary function tests and medical records for 925 children (≤19 years) diagnosed with asthma.
  • Data collected from a community-based asthma clinic between 1999 and 2011.
  • Logistic regression models used to analyze the association between FEV1, FEF25-75, and asthma-related hospitalizations.

Main Results:

  • Asthma-related hospitalization was significantly associated with decreasing categories of FEF25-75, but not FEV1.
  • Among children with a normal FEV1 (≥80% predicted), those with FEF25-75 <60% predicted were more likely to have been hospitalized (OR 2.50, 95% CI 1.17-5.35).
  • Fifty-four percent of the cohort had uncontrolled asthma symptoms, and 13% were hospitalized in the previous year.

Conclusions:

  • Reduced FEF25-75 is associated with increased asthma-related hospitalizations in children, even when FEV1 is normal.
  • FEF25-75 may serve as a critical marker for assessing asthma severity and guiding management in pediatric patients.
  • These findings highlight the importance of incorporating FEF25-75 into routine asthma assessments for children.

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
551
Antiasthma Drugs: &#946;2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
354